SURG vs. JPM

Last updated Aug 1, 2026

SURG (SurgePays, Inc.) and JPM (JPMorgan Chase & Co.) are both stocks. SURG operates in Software - Application (Technology), while JPM operates in Banks - Diversified (Financial Services). Over the past 5 years, SURG returned -47.08%/yr vs 21.31%/yr for JPM. Their 0.08 correlation means their historical movements had little consistent relationship.

Performance

SURG vs. JPM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SurgePays, Inc. (SURG) and JPMorgan Chase & Co. (JPM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SURG achieves a -86.95% return, which is significantly lower than JPM's 10.73% return.

SURG

• 1D: 0.93%
• 1M: -61.95%
• 6M: -80.88%
• YTD: -86.95%
• 1Y: -91.93%
• 3Y*: -66.07%
• 5Y*: -47.08%
• 10Y*: —
• ALL TIME*: -47.22%

JPM

• 1D: 0.27%
• 1M: 5.65%
• 6M: 16.11%
• YTD: 10.73%
• 1Y: 23.90%
• 3Y*: 33.72%
• 5Y*: 21.31%
• 10Y*: 21.80%
• ALL TIME*: 12.44%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
JPM JPMorgan Chase & Co.	$2.69B	$3.19B	$3.04B
SURG SurgePays, Inc.	$222.64K	$5.41M	$2.36M

SURG vs. JPM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
SURG SurgePays, Inc.	-86.95%	-6.18%	-72.40%	-1.68%	224.75%	-65.62%	-60.83%	-21.05%	-62.75%
JPM JPMorgan Chase & Co.	10.73%	37.27%	44.29%	30.63%	-12.64%	27.75%	-5.53%	47.26%	-11.83%

Correlation

The correlation between SURG and JPM is 0.05, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.05
Correlation (3Y) Balances recent behavior with more history.	0.10
Correlation (5Y) Shows whether the relationship held over a longer period.	0.10
Correlation (All Time) Calculated using the full available price history since Jan 16, 2018	0.08

Fundamentals

Market Cap SURG : $4.58M JPM : $942.62B
EPS SURG : -$2.12 JPM : $23.29
PS Ratio SURG : 0.09 JPM : 3.30
Total Revenue (TTM) SURG : $50.37M JPM : $297.63B
Gross Profit (TTM) SURG : -$19.42M JPM : $186.33B
EBITDA (TTM) SURG : -$40.48M JPM : $90.84B

Return for Risk

SURG vs. JPM — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

SURG

SURG Risk / Return Rank: 4
SURG Sharpe Ratio Rank: 8
SURG Sortino Ratio Rank: 2
SURG Omega Ratio Rank: 2
SURG Calmar Ratio Rank: 2
SURG Martin Ratio Rank: 5

JPM

JPM Risk / Return Rank: 71
JPM Sharpe Ratio Rank: 74
JPM Sortino Ratio Rank: 68
JPM Omega Ratio Rank: 67
JPM Calmar Ratio Rank: 72
JPM Martin Ratio Rank: 72

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

SURG vs. JPM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SurgePays, Inc. (SURG) and JPMorgan Chase & Co. (JPM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	SURG	JPM	Difference
Sharpe ratio: Return per unit of total volatility	-0.85	0.94	-1.79
Sortino ratio: Return per unit of downside risk	-2.28	1.35	-3.63
Omega ratio: Gain probability vs. loss probability	0.70	1.17	-0.47
Calmar ratio: Return relative to maximum drawdown	-0.99	1.36	-2.36
Martin ratio: Return relative to average drawdown	-1.52	3.24	-4.77

SURG vs. JPM - Sharpe Ratio Comparison

The current SURG Sharpe Ratio is -0.85, which is lower than the JPM Sharpe Ratio of 0.94. The chart below compares the historical Sharpe Ratios of SURG and JPM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

SURG vs. JPM - Drawdown Comparison

The maximum SURG drawdown since its inception was -99.66%, which is greater than JPM's maximum drawdown of -76.16%. Use the drawdown chart below to compare losses from any high point for SURG and JPM.

Drawdown Indicators

	SURG	JPM	Difference
Max Drawdown Largest peak-to-trough decline	-99.66%	-76.16%	-23.50%
Max Drawdown (1Y) Largest decline over 1 year	-92.92%	-15.47%	-77.45%
Max Drawdown (3Y) Largest decline over 3 years	-97.59%	-24.42%	-73.17%
Max Drawdown (5Y) Largest decline over 5 years	-97.59%	-38.77%	-58.82%
Max Drawdown (10Y) Largest decline over 10 years	—	-43.63%	—
Current Drawdown Current decline from peak	-99.65%	-1.54%	-98.11%
Average Drawdown Average peak-to-trough decline	-85.61%	-17.56%	-68.05%
Ulcer Index Depth and duration of drawdowns from previous peaks	60.40%	6.51%	+53.89%

Volatility

SURG vs. JPM - Volatility Comparison

SurgePays, Inc. (SURG) has a higher volatility of 47.77% compared to JPMorgan Chase & Co. (JPM) at 6.60%. This indicates that SURG's price experiences larger fluctuations and is considered to be riskier than JPM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SURG	JPM	Difference
Volatility (1M) Calculated over the trailing 1-month period	47.77%	6.60%	+41.17%
Volatility (6M) Calculated over the trailing 6-month period	87.22%	16.70%	+70.52%
Volatility (1Y) Calculated over the trailing 1-year period	108.77%	22.50%	+86.27%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	97.90%	24.46%	+73.44%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	108.82%	27.33%	+81.49%

Dividends

SURG vs. JPM - Dividend Comparison

SURG has not paid dividends to shareholders, while JPM's dividend yield for the trailing twelve months is around 1.71%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
JPM JPMorgan Chase & Co.	1.71%	1.72%	1.92%	2.38%	2.98%	2.34%	2.83%	2.37%	2.54%	1.91%	2.13%	2.54%
SURG SurgePays, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both SURG and JPM in my portfolio?

SURG and JPM have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SURG or JPM?

SURG has higher volatility (47.77%) compared to JPM (6.60%). In terms of maximum drawdown, SURG dropped -99.66% vs JPM's -76.16%.

Which has better risk-adjusted returns?

JPM currently has the higher Sharpe Ratio (0.94 vs -0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.